Benatar, M., Wuu, J., Turner, M.R. Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal. Brain, 146: 2711–2716, 2023; doi: 10.1093/brain/awac394
Braak, H., Brettschnieder, J., Ludolph, A.C., Lee, V.M., Trojanowski, J.Q., Del Tredici, K. Amyotrophic lateral sclerosis — a model of corticofugal axonal spread. Nat. Rev. Neurol., 9: 708-714, 2013; doi: 10.1038/nrneurol.2013.221
Ferrea, S., Junker, F., Korth, M., Gruhn, K., Grehl, T., Schmidt-Wilcke, T. Cortical thinning of motor and non-motor brain regions enables diagnosis of amyotrophic lateral sclerosis and support distinction between upper- and lower-motoneuron phenotypes. Biomedicines, 9: 1195, 2021; doi: 10.3390/biomedicines9091195
Jiang, J., Wang, Y., Deng, M. New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022. Front. Pharmacol., 13: 1054005, 2022; doi: 10.3389/fphar.2022.1054006
Kraft, S., Mease, C., Jillapalli, D., Fermaglich, L.J., Miller, K.L. Trends in drug development for amyotrophic lateral sclerosis. Nat. Rev. Drug Discov., 23: 99-100, 2024; doi: 10.1038/d41573-023-00199-2
Lin, Z., Kim, E., Ahmed, M., Han, G., Simmons, C., Redhead, Y., Bartlett, J., Emiliano Pena Altamera, L., Callaghan, I., White, M.A., Singh, N., Sawiak, S., Spires-Jones, T., Vernon, A.C., Coleman, M.P., Green, J., Henstridge, C., Davies, J.S., Cash, D., Sreedbaran, J. MRI-guided histology of TDP-43 knock-in mice implicates parvalbumin interneuron loss, impaired neurogenesis and aberrant neurodevelopment in amyotrophic lateral sclerosis-frontotemporal dementia. Brain Commun., 3: fcab114, 2021; doi: 10.1093/braincomms/fcab114
Liu, H., Su, S., Longitudinal assessment of TDP43 mouse brain with non-invasive MRI and MRS. FASEB J., 32(supp): 832.5, 2018; doi: 10.1016//10.1096/fasebj.2018.32.1_supplement.832.5
McCombe, P.A., Lee, J.D., Woodruff, T.M., Henderson, R.D. The peripheral immune system and amyotrophic lateral sclerosis. Front. Neuol., 11: 279, 2020; doi: 10.3389/fneur.2020.00279
Müller, H.-P., Brenner, D., Roselli, F., Wiesner, D., Abaei, A., Gorges, M., Danzer, K.M., Ludolph, A.C., Tsao, W., Wong, P.C., Rasche, V., Weishaupt, J.H., Kassubek, J. Longitudinal diffusion tensor magnetic resonance imaging analysis at the cohort level reveals disturbed cortical and callosal microstructure with spared corticospinal tract in the TDP-43G298S ALS mouse model. Transl. Neurodegener., 8: 27, 2019; doi: 10.1186/s40035-019-0163-y
Oprisan, A.L, Popescu, B.O. Dysautonomia in amyotrophic lateral sclerosis. Int. J. Mol. Sci., 24: 14927, 2023; doi: 10.3390/ijms241914927
Weerasekera, A., Crabbé, M., Tomé, S.O., Gsell, W., Sima, D., Casteels, C., Dresselaers, T., Deroose, C., Van Huffel, S., Thal, D.R., Van Damme, P., Hemmelreich, U. Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43A315T mouse model: a PET-MR study. Neuroimage Clin., 27: 102327, 2020; doi: 10.1016/j.nicl.2020.102327
Zamani, A., Walker, A.K., Rollo, B., Ayers, K.L, Farah, R, O'Brien, T.J., Wright, D.K. Impaired glymphatic function in early stages of disease in a TDP-43 mouse model of amyotrophic lateral sclerosis. Transl. Neurodegen., 11: 17, 2022; doi: 10.1186/s40035-022-00291-4
Zamani, A., Walker, A.K., Rollo, B., Ayers, K.L., Farah, R., O'Brien, T.J., Wright, D.K. Early and progressive dysfunction revealed by in vivo neurite imaging in the rNLS8 TDP-43 mouse model of ALS. Neuroimage Clin., 34: 103016, 2022; doi: 10.1016/j.nicl.2022.103016